{"date":"2026-05-17","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6892-2026-05-17-1412-zqlbyt","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-17","time":"14:12:56","subject":"公告本公司董事會通過美國孫公司SinguleraTherapeutics Inc.取得美國Mayo Clinic之CAR-Treg技術授權","clause":"第8款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-05-17 14:12，「公告本公司董事會通過美國孫公司SinguleraTherapeutics Inc.取得美國Mayo Clinic之CAR」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}